Bolloré SE : Very little upside potential, so the risk for a correction is significant
| Entry price | Target | Stop-loss | Potential |
|---|
|
€0 |
€3.9 |
€4.5 |
-∞% |
|---|
Bolloré shares can be expected to top out below the medium term resistance at 4.09 EUR. The timing appears attractive to take advantage of a correction below this level.
Strengths● The stock, which is currently worth 2019 to 0.72 times its sales, is clearly overvalued in comparison with peers.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● The stock is close to a major daily resistance at EUR 4.09, which should be gotten rid of so as to gain new appreciation potential.
● The company has insufficient levels of profitability.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
● The company's earnings releases usually do not meet expectations.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 34.64 times its estimated earnings per share for the ongoing year.
● The company is not the most generous with respect to shareholders' compensation.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
BOLLORÉ SE 
